Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin Pariente
Edouard Louis

Showing results (21-30 of 364) with videos related to

Pageof 37
Sort By:
Best Practice & Research. Clinical Gastroenterology|March 6, 2003
Optimizing treatment with thioguanine derivatives in inflammatory bowel diseaseEdouard Louis, Jacques Belaiche
Frontiers in Medicine|May 24, 2021
Editorial: Personalizing Treatment in IBD: Hype or Reality in 2020?Fernando Gomollón, Edouard Louis
Therapeutic Advances in Gastroenterology|May 17, 2023
Precision medicine and drug optimization in adult inflammatory bowel disease patientsSophie Vieujean, Edouard Louis
Gut|January 17, 2025
Challenge of treatment de-escalation in inflammatory bowel diseasesCatherine Reenaers, Edouard Louis
PET Clinics|May 10, 2016
The Role of PET/CT in the Monitoring and Diagnosis of Pediatric Inflammatory Bowel DiseaseRoland Hustinx, Edouard Louis
Gastroenterology|November 26, 2011
Adalimumab in ulcerative colitis: can pharmacodynamics be improved based on pharmacokinetics?Edouard Louis, Julián Panés
Inflammatory Bowel Diseases|November 16, 2016
Costs of Crohn's Disease According to Severity States in France: A Prospective Observational Study and Statistical Modeling over 10 YearsGilles Boschetti, Stephane Nancey, Fady Daniel, et al.
Digestive Diseases (Basel, Switzerland)|June 28, 2014
Can we predict the high-risk patient?Jose-Manuel Benitez, Edouard Louis
Gastroenterology|March 30, 2016
ReplyBenjamin Pariente, Pauline Wils, David Laharie
World Journal of Gastroenterology|June 3, 2010
Do clinical factors help to predict disease course in inflammatory bowel disease?Edouard Louis, Jacques Belaiche, Catherine Reenaers
Pageof 37

Showing results (21-30 of 364) with videos related to

Sort By:
Pageof 37
Best Practice & Research. Clinical Gastroenterology|March 6, 2003
Optimizing treatment with thioguanine derivatives in inflammatory bowel diseaseEdouard Louis, Jacques Belaiche
Frontiers in Medicine|May 24, 2021
Editorial: Personalizing Treatment in IBD: Hype or Reality in 2020?Fernando Gomollón, Edouard Louis
Therapeutic Advances in Gastroenterology|May 17, 2023
Precision medicine and drug optimization in adult inflammatory bowel disease patientsSophie Vieujean, Edouard Louis
Gut|January 17, 2025
Challenge of treatment de-escalation in inflammatory bowel diseasesCatherine Reenaers, Edouard Louis
PET Clinics|May 10, 2016
The Role of PET/CT in the Monitoring and Diagnosis of Pediatric Inflammatory Bowel DiseaseRoland Hustinx, Edouard Louis
Gastroenterology|November 26, 2011
Adalimumab in ulcerative colitis: can pharmacodynamics be improved based on pharmacokinetics?Edouard Louis, Julián Panés
Inflammatory Bowel Diseases|November 16, 2016
Costs of Crohn's Disease According to Severity States in France: A Prospective Observational Study and Statistical Modeling over 10 YearsGilles Boschetti, Stephane Nancey, Fady Daniel, et al.
Digestive Diseases (Basel, Switzerland)|June 28, 2014
Can we predict the high-risk patient?Jose-Manuel Benitez, Edouard Louis
Gastroenterology|March 30, 2016
ReplyBenjamin Pariente, Pauline Wils, David Laharie
World Journal of Gastroenterology|June 3, 2010
Do clinical factors help to predict disease course in inflammatory bowel disease?Edouard Louis, Jacques Belaiche, Catherine Reenaers
Pageof 37